Clinical Trial

NobelZygoma TiUltra Implant System Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this prospective study is to assess short term (12-months) clinical outcomes of NobelZygoma TiUltra implants and Multi-unit Abutment Xeal in the rehabilitation of participants with severely atrophic maxilla treated with zygomatic dental implant procedure. The main goal is to assess the sinusitis occurrence at 12-months after implant insertion. Other objectives are to assess: soft tissue health; biological and technical complication; patient's experience, outcomes (sinonasal symptoms and oral health-related quality of life) and satisfaction; clinician's experience with handling of device and satisfaction; implant, abutment and prosthetic survival and adverse events. Participants will be asked to complete questionnaires at pretreatment visit, postoperative visit, and after 6-months and 12-months of implant insertion. At 12-months a radiological exam (CBCT) will be asked for the participant for the evaluation of the radiological condition of the maxillary sinus.
Trial Details
NCT Number NCT07258940
Lead Sponsor Nobel Biocare
Conditions Edentulous Maxilla, Maxillary Bone Loss, Atrophic Maxilla
Enrollment 85 participants
Start Date 2026-06-01
Primary Completion 2028-11-01 (estimated)
Study Completion 2029-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-02